MicroRNAs in Obesity and Related Metabolic Disorders
AbstractMetabolic disorders are characterized by the inability to properly use and/or store energy. The burdens of metabolic disease, such as obesity or diabetes, are believed to arise through a complex interplay between genetics and epigenetics predisposition, environment and nutrition. Therefore, understanding the molecular mechanisms for the onset of metabolic disease will provide new insights for prevention and treatment. There is growing concern about the dysregulation of micro-RNAs (miRNAs) in metabolic diseases. MiRNAs are short non-coding RNA molecules that post-transcriptionally repress the expression of genes by binding to untranslated regions and coding sequences of the target mRNAs. This review aims to provide recent data about the potential involvement of miRNAs in metabolic diseases, particularly obesity and type 2 diabetes. View Full-Text
Share & Cite This Article
Landrier, J.-F.; Derghal, A.; Mounien, L. MicroRNAs in Obesity and Related Metabolic Disorders. Cells 2019, 8, 859.
Landrier J-F, Derghal A, Mounien L. MicroRNAs in Obesity and Related Metabolic Disorders. Cells. 2019; 8(8):859.Chicago/Turabian Style
Landrier, Jean-François; Derghal, Adel; Mounien, Lourdes. 2019. "MicroRNAs in Obesity and Related Metabolic Disorders." Cells 8, no. 8: 859.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.